Page last updated: 2024-11-06

tolmesoxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

tolmesoxide: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID72153
CHEMBL ID1097904
SCHEMBL ID2109962
MeSH IDM0065950

Synonyms (28)

Synonym
4,5-dimethoxy-2-(methylsulfinyl)toluene
tolmesoxide
nsc321277
38452-29-8
nsc-321277
rx-71107
1,2-dimethoxy-4-methyl-5-methylsulfinylbenzene
CHEMBL1097904
nsc 321277
tolmesoxide [inn:ban]
tolmesoxido [inn-spanish]
tolmesoxidum
tolmesoxido
hhr1khp34n ,
1,2-dimethoxy-4-methyl-5-(methylsulfinyl)benzene
tolmesoxidum [inn-latin]
unii-hhr1khp34n
tolmesoxide [inn]
(+/-)-4,5-dimethoxy-2-(methylsulfinyl)toluene
SCHEMBL2109962
sr-01000944970
SR-01000944970-1
AKOS033116969
rx 71107
Q27279940
DTXSID80865917
1-(methanesulfinyl)-4,5-dimethoxy-2-methylbenzene
Z1154953662

Research Excerpts

Overview

Tolmesoxide is a new, direct-acting vasodilator drug for use in the management of both hypertension and cardiac failure.

ExcerptReferenceRelevance
"Tolmesoxide is a new, direct-acting vasodilator drug for use in the management of both hypertension and cardiac failure. "( The effect of food on the pharmacokinetics and pharmacodynamics of tolmesoxide in essential hypertensives.
Elliott, HL; Hughes, MA; McLean, K; Meredith, PA; Reid, JL, 1982
)
1.94

Bioavailability

ExcerptReferenceRelevance
" The bioavailability of oral tolmesoxide from capsules averaged 84."( Pharmacokinetics of intravenous and oral tolmesoxide.
Clifford, JM; Greenslade, D; Henson, R; Lloyd-Jones, JG; Nichols, JD, 1981
)
0.82

Dosage Studied

ExcerptRelevanceReference
" The haemodynamic effects and pharmacokinetic profile of acute dosing with tolmesoxide, a new vasodilator antihypertensive agent are described."( The clinical pharmacology of vasodilator antihypertensive drugs.
Kelly, JG; McNay, JL; O'Boyle, C; O'Brien, ET; O'Malley, K, 1980
)
0.49
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID476929Human intestinal absorption in po dosed human2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (93.75)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (6.25)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (12.50%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]